ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - paricalcitol - תמיסה להזרקה - paricalcitol 5 mcg/ml - paricalcitol - paricalcitol - paricalcitol is indicated for the prevention and treatment of secondary hyperparathyrodism associated with chronic renal failure.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - paricalcitol - קפסולות - paricalcitol 1 mcg - paricalcitol - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - paricalcitol 2 mcg - capsules - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - paricalcitol 4 mcg - capsules - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.

ישראל - עברית - Ministry of Health

inovamed ltd - paricalcitol - תמיסה להזרקה - paricalcitol 0.005 mg/ml - paricalcitol

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - paricalcitol - קפסולות רכות - paricalcitol 1 mcg - paricalcitol

ישראל - עברית - Ministry of Health

unipharm ltd, israel - paricalcitol - תמיסה להזרקה - paricalcitol 0.005 mg / 1 ml - paricalcitol